APA (7th ed.) Citation

Li, Y., Li, L., Mao, Q., Liu, S., Shen, Y., Zhao, W., . . . Chen, X. (2025). Ifebemtinib and paclitaxel synergistically inhibit the proliferation and metastasis of TNBC by blocking PI3K/Akt pathway through LSD1/PIK3IP1 axis. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-26828-x

Chicago Style (17th ed.) Citation

Li, Yong, Lianfang Li, Qixin Mao, Shanqing Liu, Yan Shen, Wanying Zhao, Shaohua Zheng, Sai-Qi Wang, and Xiao-Bing Chen. "Ifebemtinib and Paclitaxel Synergistically Inhibit the Proliferation and Metastasis of TNBC by Blocking PI3K/Akt Pathway Through LSD1/PIK3IP1 Axis." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-26828-x.

MLA (9th ed.) Citation

Li, Yong, et al. "Ifebemtinib and Paclitaxel Synergistically Inhibit the Proliferation and Metastasis of TNBC by Blocking PI3K/Akt Pathway Through LSD1/PIK3IP1 Axis." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-26828-x.